期刊文献+

胃癌患者外周血中T细胞亚群变化及临床意义 被引量:3

The Changes of T Cell Subsets in Peripheral Blood of Patients with Gastric Cancer and Its Clinical Significance
下载PDF
导出
摘要 目的:探讨胃癌患者外周血T细胞亚群的变化及其对评估胃癌患者机体免疫状态的临床意义。方法:流式细胞术分析40例术前胃癌患者及30名健康人群(对照组)外周血中T细胞亚群(CD3+、CD4+、CD8+T细胞、CD4+/CD8+比值),组间比较采用t检验,检验水准a=0.05。结果:研究组胃癌患者外周血CD3+、CD4+T细胞、CD4+/CD8+比值明显低于健康人群对照组,差异有统计学意义(P值均<0.05),而两组间CD8+T细胞的差异无统计学意义(P>0.05);肿瘤侵及浆膜组CD3+、CD4+T细胞、CD4+/CD8+比值明显低于未侵及浆膜组,差异有统计学意义(P值均<0.05);肿瘤有淋巴结转移组CD3+、CD4+T细胞、CD4+/CD8+比值明显低于肿瘤无淋巴结转移组,差异有统计学意义(P值均<0.05);肿瘤临床分期TNMⅢ、Ⅳ期组CD3+、CD4+T细胞、CD4+/CD8+比值明显低于TNMⅠ、Ⅱ期组,差异有统计学意义(P值均<0.05);肿瘤高中分化组和低分化组间CD3+、CD4+T细胞、CD4+/CD8+比值的差异无统计学意义(P值均>0.05),各不同组间外周血CD8+T细胞的差异无统计学意义(P值均>0.05)。结论:胃癌患者术前外周血T细胞亚群对评估胃癌患者机体免疫状态有一定的临床意义,也为肿瘤的免疫增强治疗提供了理论依据。 Objective Explore the changes of T cell subsets in peripheral blood of patients with gastric cancer and its clinical significance to assess the immune status of patients with gastric cancer. Methods Using flow cytometry to analys 40 cases of preoperative patients with gastric cancer and 30 healthy people(control group) in peripheral blood T cell subsets (CD3+、CD4+ T cells, CD4+/CD8+ ratio). Inter-group comparison t test were used, significance level a = 0.05. Results CD3+, CD4+ T cells, CD4+/CD8+ ratio of gastric cancer patients study group was significantly lower than those of the healthy control group, the difference had statistical significance (All P values 〈 0.05), and between the two groups of CD8+T cells, difference had no significant(P 〉 0.05); Serosal invasion tumor group CD3+, CD4+T cells, CD4+/CD8+ ratio were significantly lower than those of no serosal invasion group, the difference had statistical significance (All P value 〈 0.05); tumor with lymph node metastasis group CD3+、CD4+
出处 《深圳中西医结合杂志》 2009年第3期138-141,共4页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
关键词 T细胞 流式细胞术 胃癌 T cell Flow cytometry Gastric cancer
  • 相关文献

参考文献12

  • 1Lissni P, Brivio F, Ferranle R,et al.Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cance [J].Int J BiolMarkets,2002,12(1):22-25.
  • 2Decensi A,Costa A.Recent advances in cancer chemoprevention with emphasis on breast and cancer [J].Eur J Cancer,2002,3(6):694-709.
  • 3陈复兴,刘军权,周忠海,张南征,张国龙,李晓洲.癌症患者T细胞亚群的临床意义[J].细胞与分子免疫学杂志,2002,18(1):55-55. 被引量:40
  • 4Blue ML,Daley JF, Levine H,et al.Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry [J].J Immunol,1985,134: 2281-2286.
  • 5曾瑞红,房桂珍,魏林.CD4^+ T细胞在肿瘤免疫治疗中的作用[J].细胞生物学杂志,2008,30(1):30-34. 被引量:30
  • 6Advani SH,Kutty PM,Gopal R, et al.Immunity in oesophageal carcinoma [J].J Surg Oncol, 1983,24(4):268-273.
  • 7Saito T, Shimoda K,Kinoshita T, et al.Prediction of operativemortality based on impairment of host defense systems in patients with esophageal cancer [J].J Surg Oncol,1993,52(1):1-8.
  • 8Mitropoulos D,Alamanis C,Deliveliotis C,et al.T lymphocyte subsets in the peripheral blood of patients with renal cell carcinoma [J].Acta Urol Belg, 1995,63(3):21-25.
  • 9Dick HM.Monoclonal antibody in clinical medicine [J]. Br Med J, 1985,21,(6498):762-764.
  • 10Tvartter PT, Martnelli G,Steinberg B,et al.Change in peripheral T-cell-subsets and natural killer cytotoxicity in relation to colorectal cancer surgery [J].Cancer Detect Prev,1986,9(4):359-364.

二级参考文献45

  • 1李晓洲,陈复兴,姚仁南,黄晓静,朱月蓉,吕杭,骆晓梅.全血细胞计数仪测定指数对肝病的诊断价值[J].肝脏,1998,3(4):60-61. 被引量:2
  • 2梁业民,吕惠兰,梁超前,杨欣,木兰.直肠癌患者外周血 T 细胞及其亚群的研究[J].齐鲁肿瘤杂志,1997,4(2):110-111. 被引量:2
  • 3Jackson PA, Green MA,Mark CG, et al. Lymphocyte subset infiltration patterns and HLA antigen status incolorectal carcinomas and adenomas[J]. Gut, 1996:38 (1) :85.
  • 4Robin LA, Neson DL. The soluble interleukin-2receptor biology function and clinical application[J]. Ann Inter Med, 1990, 113(8) :619 -621.
  • 5Mitchison NA. Eur J Immunol, 1971, 1:18.
  • 6Park H et al. Nat lmmunol, 2005, 6:1133.
  • 7Bettelli E et al. Nature. 2006. 441:235.
  • 8Deepak PA et al. Cancer Immunol lmmunother, 2006, 55: 1135.
  • 9Segal BM et al. J lmmunol, 2002, 168:1.
  • 10Hung K et al. J Exp Med, 1998, 188:2357.

共引文献96

同被引文献24

  • 1何春年,刘贵香,翟金萍,徐翠清,赵焕芬,孙金海.子宫颈鳞癌组织中T、B、NK淋巴细胞浸润与肿瘤免疫[J].免疫学杂志,2005,21(B06):115-118. 被引量:4
  • 2李进东,许金良,王文光,赵婷茹,马杰.肺癌患者外周血T淋巴细胞亚群的变化[J].中国医师进修杂志(外科版),2006,29(11):25-27. 被引量:24
  • 3Shen Z, Zhou S, Wang Y, et al. Higher intratumoral infil- trated Foxp3^+ Treg numbers and Foxp3^+/CD8^+ ratio are asso- ciated with adverse prognosis in resectable gastric cancer[J]. Cancer Res Clin Oncol, 2010, 11(1): 1-3.
  • 4Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity[J]. Int J Cancer, 2010, 127(12):759-767.
  • 5Kelley T W, Parker CJ. CD4^+CD25^+Foxp3^+ regulatory T cells and hematologic malignancies[J]. Front Biosci, 2010, 22(6): 980-992.
  • 6Ono M, Yaguchi H, Ohkura N, et a/. Foxp3 controls regula- tory T-cell function by interacting with AML1/Runxl[J]. Nature, 2007, 446 (4) :685-689.
  • 7Woo EY, Yeh H, Chu CS, et al. Regulatory CD4^+CD25^+T cells in tumors from patients with early stage non-smaU cell lung cancer and late-stage overian cancer[J]. Cancer Res, 2001,61(8):4766-4772.
  • 8Gajewski TF. The expanding universe of regulatory T cell subsets in cancer[J]. Immunity, 2007, 27(8): 185-187.
  • 9Waldmann TA. Effective cancer therapy through immuno- modulationFJ. Annu Rev Med, 2006,57(1) : 65-81.
  • 10Thio CL, Mosbruger TL,Kaslow RA, et al. Cytotoxic T lymphocyte antigen 4 gene and recovery from hepatitis B virus infection[J]. J Virol,2004,78(20) : 11258-11262.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部